Urinary Angiotensinogen as a Novel Early Biomarker of Intrarenal Renin^|^ndash;Angiotensin System Activation in Experimental Type 1 Diabetes

DOI Web Site PubMed 被引用文献4件 参考文献138件
  • Kamiyama Masumi
    Department of Physiology, Tulane University Health Sciences Center, USA Hypertension and Renal Center of Excellence, Tulane University Health Sciences Center, USA
  • Zsombok Andrea
    Department of Physiology, Tulane University Health Sciences Center, USA Hypertension and Renal Center of Excellence, Tulane University Health Sciences Center, USA Department of Medicine, Tulane University Health Sciences Center, USA
  • Kobori Hiroyuki
    Department of Physiology, Tulane University Health Sciences Center, USA Hypertension and Renal Center of Excellence, Tulane University Health Sciences Center, USA Department of Medicine, Tulane University Health Sciences Center, USA

書誌事項

タイトル別名
  • Urinary Angiotensinogen as a Novel Early Biomarker of Intrarenal Renin–Angiotensin System Activation in Experimental Type 1 Diabetes

この論文をさがす

説明

Urinary excretion of albumin (UAlb) is used clinically as a marker of diabetic nephropathy (DN). Although DN was thought to be a unidirectional process, recent studies demonstrated that a large proportion of patients diagnosed with DN reverted to normoalbuminuria. Moreover, despite the normoalbuminuria, one-third of them exhibited reduced renal function even during the microalbuminuric stage. This study was performed to investigate whether urinary angiotensinogen (UAGT) level may serve as a useful marker of the early stage of experimental type 1 diabetes (T1DM). T1DM was induced by a single intraperitoneal injection of streptozotocin. Control mice were injected with citrate buffer. Two days after streptozotocin injection, half of the mice received continuous insulin treatment. Our data showed that UAlb excretion was increased 6 days after streptozotocin injection compared to controls, whereas UAGT excretion was increased at an earlier time point. These increases were reversed by insulin treatment. The UAGT to UAlb ratio was increased in diabetic mice compared to control mice. Furthermore, the increased AGT expression in the kidneys was observed in diabetic mice. These data suggest that UAGT might be useful as a novel early biomarker of activation of the renin–angiotensin system in experimental type 1 diabetes.

収録刊行物

被引用文献 (4)*注記

もっと見る

参考文献 (138)*注記

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ